Gabrielli, Maurizio
 Distribuzione geografica
Continente #
EU - Europa 4.704
NA - Nord America 3.243
AS - Asia 2.236
SA - Sud America 441
AF - Africa 35
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.679
Nazione #
US - Stati Uniti d'America 3.152
DE - Germania 2.333
SG - Singapore 879
CN - Cina 769
SE - Svezia 608
IT - Italia 403
BR - Brasile 377
UA - Ucraina 294
FR - Francia 246
GB - Regno Unito 233
IE - Irlanda 120
FI - Finlandia 117
IN - India 117
VN - Vietnam 100
PL - Polonia 93
TR - Turchia 82
ID - Indonesia 80
RU - Federazione Russa 72
CA - Canada 52
JP - Giappone 40
BE - Belgio 34
HK - Hong Kong 33
NL - Olanda 29
MX - Messico 28
ES - Italia 24
AR - Argentina 23
IR - Iran 23
BD - Bangladesh 16
KR - Corea 16
CH - Svizzera 13
LT - Lituania 13
AU - Australia 12
CO - Colombia 12
ZA - Sudafrica 12
AT - Austria 11
RO - Romania 11
IQ - Iraq 10
CZ - Repubblica Ceca 9
EC - Ecuador 9
SA - Arabia Saudita 8
MY - Malesia 7
PT - Portogallo 7
TW - Taiwan 7
AE - Emirati Arabi Uniti 6
CI - Costa d'Avorio 6
CL - Cile 6
PK - Pakistan 6
UZ - Uzbekistan 6
AL - Albania 5
AZ - Azerbaigian 5
EG - Egitto 5
IL - Israele 5
LK - Sri Lanka 4
PE - Perù 4
PH - Filippine 4
PY - Paraguay 4
AO - Angola 3
BY - Bielorussia 3
BZ - Belize 3
EU - Europa 3
GR - Grecia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
A1 - Anonimo 2
BO - Bolivia 2
BS - Bahamas 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
LV - Lettonia 2
MA - Marocco 2
ME - Montenegro 2
RS - Serbia 2
VA - Santa Sede (Città del Vaticano) 2
AM - Armenia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GN - Guinea 1
HN - Honduras 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
Totale 10.676
Città #
Chandler 580
Singapore 466
Ashburn 285
Nürnberg 153
Jacksonville 144
Beijing 140
San Mateo 133
Dublin 115
Ann Arbor 112
Nanjing 111
New York 84
Munich 83
Jakarta 73
Hefei 68
Dearborn 67
Wilmington 67
Izmir 63
Marseille 62
Los Angeles 61
Boston 57
Woodbridge 56
The Dalles 54
Rome 51
Princeton 49
Frankfurt am Main 47
Milan 47
Houston 45
Nanchang 44
Bremen 43
Warsaw 42
Ho Chi Minh City 41
Seattle 39
Helsinki 35
Redwood City 35
Brussels 34
Hong Kong 32
Lancaster 32
Kraków 31
Moscow 31
São Paulo 31
Fuzhou 30
Chicago 29
Boardman 25
Dallas 24
Shenyang 24
Tokyo 24
Fairfield 23
Turku 23
University Park 23
Buffalo 22
Cattolica 20
Hangzhou 20
Leawood 19
Guangzhou 18
Augusta 17
Hanoi 17
Hebei 17
London 17
Kunming 16
Norwalk 16
Tianjin 16
Changsha 15
Falls Church 15
Lawrence 15
Montreal 15
Toronto 15
Fremont 14
Zhengzhou 14
Brooklyn 13
Mountain View 13
Rio de Janeiro 13
Santa Clara 13
Seoul 13
Jiaxing 12
Kent 12
Nuremberg 12
Belo Horizonte 11
Bexley 11
Palermo 11
Shanghai 11
Mumbai 10
Phoenix 10
Düsseldorf 9
Lauterbourg 9
Mexico City 9
Pune 9
Wroclaw 9
Morgantown 8
San Francisco 8
Atlanta 7
Chennai 7
Denver 7
Florence 7
Jinan 7
Johannesburg 7
Kish 7
Ottawa 7
Paris 7
Porto Alegre 7
Roubaix 7
Totale 4.589
Nome #
-Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth 484
The Role of Methane in Intestinal Diseases. 408
Small intestinal bacterial overgrowth recurrence after antibiotic therapy 398
Interaction between Helicobacter pylori infection and untreated coeliac disease on gastric histological pattern. 340
-Azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome 287
Bacillus clausii as a treatment of small intestinal bacterial overgrowth. 261
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 242
ag)Association between hypothyroidism and small intestinal bacterial overgrowth 238
The role of intestinal microbiota and the immune system 223
The role of small intestinal bacterial overgrowth in Parkinson's disease 219
-High prevalence of celiac disease in patients with lactose intolerance 205
Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? 204
The effect of oral supplementation with Lactobacillus reuteri or tilactase in lactose intolerant patients: randomized trial 190
Small intestinal bacterial overgrowth and intestinal permeability. 182
Use of oxycodone in polytrauma patients: the "Gemelli" experience 177
A) CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke. 177
Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture 173
A) Treatment of ischemic ulcers of the lower limbs with alprostadil (prostaglandin E1). 161
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. 154
A simplified way for the urgent treatment of somatic pain in patients admitted to the emergency room: the SUPER algorithm 154
Rifaximin pharmacology and clinical implications. 152
-Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth 148
. High prevalence of Cag-A positive H. pylori strains in ischemic stroke: a primary care multicenter study. 147
Post-exercise high-sensitivity troponin T levels in patients with suspected unstable angina 147
A) Effects of mineral-water supplementation on gastric emptying of solids in patients with functional dyspepsia assessed with the 13C-octanoic-acid breath test. 146
-Idiopathic chronic urticaria and celiac disease 146
High reinfection rate of Helicobacter pylori in young type 1 diabetic patients: a three-year follow-up study 146
Prevalence of small intestinal bacterial overgrowth in Parkinson's disease 139
Safety and efficacy of low doses of diclofenac on acute pain in the emergency setting 137
[Helicobacter pylori and gastric carcinoma] 136
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. 135
Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole 134
Regression of lactose malabsorption in coeliac patients after receiving a gluten-free diet. 131
Small intestinal bacterial overgrowth: diagnosis and treatment 131
ag) Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study. 130
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study 130
Colitides 129
Celiac disease and chronic urticaria resolution: a case report. 129
Sarilumab use in severe SARS-CoV-2 pneumonia 128
-Can 13C urea breath test predict resistance to therapy in Helicobacter pylori infection? 126
Idiopathic chronic urticaria and celiac disease 125
Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth 121
Rifaximin-based regimens for eradication of Helicobacter pylori: a pilot study. 120
Resolution of migraine with aura after successful treatment of a pituitary microadenoma 120
The use of probiotics in different phases of diverticular disease 119
Re: "Chronic Helicobacter pylori infection and migraine: a case-control study" (Pinessi L, Savi L, Pellicano R, et al. Headache. 2000;40:836-839) 108
Microbes and Alzheimer' disease: Lessons from H. Pylori and GUT microbiota 108
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 105
Helicobacter pylori: a culprit in extraintestinal diseases? 104
Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. 101
Probiotics: which and when? 101
COVID-19 and thrombotic complications: Pulmonary thrombosis rather than embolism? 99
Atrophic gastritis as a cause of hyperhomocysteinaemia 98
Latent coeliac disease, hyperhomocysteinemia and pulmonary thromboembolism: a close link? 97
Seroprevalence of chronic infections in migraine 95
The relationship between chronic H. pylori infection, CagA seropositivity and stroke: meta-analysis 94
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards 90
Is BMI Associated with Covid-19 Severity? A Retrospective Observational Study 89
Primary autoimmune haemolytic anaemia and coeliac disease 89
No association between post-exercise high-sensitivity troponin T levels and CAD 85
The interaction between small intestinal bacterial overgrowth and warfarin treatment 80
Autonomic dysfunction in non-critically ill COVID-19 patients during the acute phase of disease: an observational, cross-sectional study 79
-Helicobacter pylori and extragastric diseases--other Helicobacters 78
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. pylori infection 78
Is BMI Associated with COVID-19 Severity? A Retrospective Observational Study 77
-The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis. 76
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 75
Instrumental Evaluation of COVID-19 Related Dysautonomia in Non-Critically-Ill Patients: An Observational, Cross-Sectional Study 72
Coffee and Microbiota: A Narrative Review 64
Are Short-Stay Units Safe and Effective in the Treatment of Non-Variceal Upper Gastrointestinal Bleeding? 63
Teaching suturing skill to emergency physicians: the experience of a hands-on practical training in a laboratory simulation-based setting 62
Role of Fecal Calprotectin in Patients Presenting to the Emergency Department with Abdominal Pain with or without Diarrhea or Rectal Bleeding 58
Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy 58
Correction to: Asthma in patients admitted to emergency department for COVID‑19: prevalence and risk of hospitalization 58
Gastrointestinal Bleeding Due to NOACs Use: Exploring the Molecular Mechanisms 43
Correction to: Asthma in patients admitted to emergency department for COVID‑19: prevalence and risk of hospitalization 32
Totale 10.745
Categoria #
all - tutte 38.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021549 0 0 0 0 118 35 71 25 80 46 162 12
2021/2022704 28 75 19 38 59 19 16 122 29 48 101 150
2022/20231.625 248 225 135 280 91 162 99 117 169 27 42 30
2023/2024700 42 180 22 27 24 104 38 52 14 39 77 81
2024/20251.506 26 61 143 47 128 45 41 91 183 139 325 277
2025/20261.681 601 135 210 410 325 0 0 0 0 0 0 0
Totale 10.745